SPARC is a major secretory gene expressed and involved in the development of proliferative diabetic retinopathy

Journal of Atherosclerosis and Thrombosis

Volumn 16, Issue 2, 2009, Pages 69-76

  Watanabe, Kazuhisa ^a   Okamoto, Fumiki ^a   Yokoo, Tomotaka ^a,b   Iida, Kaoruko Tada ^a   Suzuki, Hiroaki ^a   Shimano, Hitoshi ^a   Oshika, Tetsuro ^a   Yamada, Nobuhiro ^a   Toyoshima, Hideo ^a,b  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Neovascularization; Proliferative diabetic retinopathy; Secreted protein acidic and rich in cystein

Indexed keywords

OSTEONECTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY; DNA LIBRARY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; RAT; UNINDEXED SEQUENCE; VITREOUS BODY;

EID: 67549112819     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.E711     Document Type: Article

References (20)

1. Frank RN: Diabetic retinopathy. N Engl J Med, 2004; 350:48-58
2. von Heijne G: Signal sequences. The limits of variation. J Mol Biol, 1985; 184:99-105
3. Kojima T, Kitamura T: A signal sequence trap based on a constitutively active cytokine receptor. Nat Biotechnol, 1999; 17:487-490
4. Ohgaki S, Iida K, Yokoo T, Watanabe K, Kihara R, Suzuki H, Shimano H, Toyoshima H, Yamada N: Identification of ISG12b as a putative interferon-inducible adipocytokine which is highly expressed in white adipose tissue. J Atheroscler Thromb, 2007; 14:179-184
5. Ishikawa M, Okajima F, Inoue N, Motomura K, Kato T, Takahashi A, Oikawa S, Yamada N, Shimano H: Distinct effects of pravastatin, atorvastatin, and simvastatin on insulin secretion from a beta-cell line, MIN6 cells. J Atheroscler Thromb, 2006; 13:329-335
6. Suzuki M, Kakuta H, Takahashi A, Shimano H, Tada-Iida K, Yokoo T, Kihara R, Yamada N: Effects of atorvastatin on glucose metabolism and insulin resistance in KK/Ay mice. J Atheroscler Thromb, 2005; 12:77-84
7. Oshima Y, Takahashi K, Oshima S, Saishin Y, Silva RL, Liang X, Reddy PS, Ganesh S, Brann T, Liau G, Kaleko M, Connelly S, Campochiaro PA: Intraocular gutless adenoviral-vectored VEGF stimulates anterior segment but not retinal neovascularization. J Cell Physiol, 2004; 199:399-411
8. Baffi J, Byrnes G, Chan CC, Csaky KG: Choroidal neovascularization in the rat induced by adenovirus mediated expression of vascular endothelial growth factor. Invest Ophthalmol Vis Sci, 2000; 41:3582-3589
9. Spilsbury K, Garrett KL, Shen WY, Constable IJ, Rakoczy PE: Overexpression of vascular endothelial growth factor (VEGF) in the retinal pigment epithelium leads to the development of choroidal neovascularization. Am J Pathol, 2000; 157:135-144
10. D'Amato R, Wesolowski E, Smith LE: Microscopic visualization of the retina by angiography with high-molecular-weight fluorescein-labeled dextrans in the mouse. Microvasc Res, 1993; 46:135-142
11. Hammes HP, Lin J, Bretzel RG, Brownlee M, Breier G: Upregulation of the vascular endothelial growth factor/vascular endothelial growth factor receptor system in experimental background diabetic retinopathy of the rat. Diabetes, 1998; 47:401-406
12. Gilbert RE, Cox AJ, Kelly DJ, Wilkinson-Berka JL, Sage EH, Jerums G, Cooper ME: Localization of secreted protein acidic and rich in cysteine (SPARC) expression in the rat eye. Connect Tissue Res, 1999; 40:295-303
13. Bradshaw AD, Sage EH: SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury. J Clin Invest, 2001; 107:1049-1054
14. Lane TF, Iruela-Arispe ML, Johnson RS, Sage EH: SPARC is a source of copper-binding peptides that stimulate angiogenesis. J Cell Biol, 1994; 125:929-943
15. Sage EH, Reed M, Funk SE, Truong T, Steadele M, Puolakkainen P, Maurice DH, Bassuk JA: Cleavage of the matricellular protein SPARC by matrix metalloproteinase 3 produces polypeptides that influence angiogenesis. J Biol Chem, 2003; 278:37849-37857
16. Iruela-Arispe ML, Lane TF, Redmond D, Reilly M, Bolender RP, Kavanagh TJ, Sage EH: Expression of SPARC during development of the chicken chorioallantoic membrane: evidence for regulated proteolysis in vivo. Mol Biol Cell, 1995; 6:327-343
17. Taneda S, Pippin JW, Sage EH, Hudkins KL, Takeuchi Y, Couser WG, Alpers CE: Amelioration of diabetic nephropathy in SPARC-null mice. J Am Soc Nephrol, 2003; 14:968-980
18. Takahashi M, Nagaretani H, Funahashi T, Nishizawa H, Maeda N, Kishida K, Kuriyama H, Shimomura I, Maeda K, Hotta K, Ouchi N, Kihara S, Nakamura T, Yamashita S, Matsuzawa Y: The expression of SPARC in adipose tissue and its increased plasma concentration in patients with coronary artery disease. Obes Res, 2001; 9:388-393
19. Sheridan CM, Magee RM, Hiscott PS, Hagan S, Wong DH, McGalliard JN, Grierson I: The role of matricellular proteins thrombospondin-1 and osteonectin during RPE cell migration in proliferative vitreoretinopathy. Curr Eye Res, 2002; 25:279-285
20. Kato Y, Lewalle JM, Baba Y, Tsukuda M, Sakai N, Baba M, Kobayashi K, Koshika S, Nagashima Y, Frankenne F, Noel A, Foidart JM, Hata RI: Induction of SPARC by VEGF in human vascular endothelial cells. Biochem Biophys Res Commun, 2001; 287:422-426